Latest News

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

ADAPs achieve 87% viral suppression but face funding crisis as multiple policies erode 340B rebates.

FY2026 preserves HIV funding but level funding can't support long-acting therapeutics or growing needs.

Q1 2026 Watch: HCV/HIV co-infection treatment access under evolving federal and state policies.

2025 healthcare crises result from policy choices as ACA subsidies expire, HIV care deteriorates, and state pricing experiments proliferate.

HIV care system deterioration from administrative obstruction and funding delays presages catastrophic effects of potential budget cuts.

Federal policy changes including Medicaid work requirements and ADAP eligibility restrictions threaten access to HIV medications.

Q4 2025 Watch monitoring HCV treatment access and federal initiatives including Cure Hepatitis C Act.

Government shutdown disrupts grant payments to community health centers and crisis service providers, threatening vulnerable population access.

Proposed PEPFAR defunding would eliminate the world's most successful global HIV program and damage international health capacity.

Q3 2025 Watch: critical analysis including Cure Hepatitis C Act proposing subscription treatment models.

Impending HIV care crisis results from Medicaid work requirements, federal funding cuts, and healthcare system fragmentation.

HHS budget proposal would eliminate critical HIV prevention funding and reduce Ryan White HIV/AIDS program resources.

Q2 2025 Watch monitoring HCV and HIV treatment access through ADAPs, Medicaid, and federal assistance.

Proposed Medicaid cuts and work requirements threaten coverage for millions including people living with HIV.

Q1 2025 Watch: comprehensive update on HIV/HCV co-infection treatment access across federal and state programs.

Healthcare policy opportunities and threats during lame duck congressional session.

Bipartisan HCV elimination legislation analysis and critical legislative window.

Partisan political battles threaten essential public health programs and HIV funding.

Q4 2024 Watch: HCV treatment access assessment with guidance for disaster-displaced individuals.